Table 4.
Logistic regression analysis of risk factors for ISR
| Variables | Univariate | Multivariate* | ||
|---|---|---|---|---|
| OR (95%CI) | P | OR (95%CI) | P | |
| TC (mmol/L) | 0.76 (0.60–0.97) | 0.03 | 0.92 (0.53–1.62) | 0.92 |
| LDL (mmol/L) | 0.66 (0.47–0.91) | 0.01 | 0.57 (0.26–1.24) | 0.16 |
| Stent length (mm) | 0.96 (0.92–1.00) | 0.07 | 0.97 (0.92–1.03) | 0.29 |
| LVEF (%) | 0.98 (0.96–0.99) | 0.03 | 0.97 (0.94–0.99) | 0.04 |
| Stent number | 4.15 (2.73–6.31) | < 0.01 | 3.99 (2.24–7.10) | < 0.01 |
| Rapamycin stent | 0.57 (0.25–1.29) | 0.176 | 0.64 (0.22–1.89) | 0.41 |
OR odd ratio, CI confidence interval, TC total cholesterol, LDL low-density lipoprotein, LVEF left ventricular ejection fraction
*Adjusted for gender, age, hypertension, diabetes mellitus, statin therapy, ticagrelor therapy, aspirin therapy, ACEI/ARB therapy, and stent diameter